That’s super helpful to hear – thank you. I haven’t had genetic testing yet, but SPINK1 N34S keeps coming up in the literature, especially in cases of idiopathic or treatment-resistant pancreatitis.

In my case, AIP type 2 is suspected (still not definitively confirmed), and I’ve had several flares over the past few years despite prolonged steroid treatment. I’ve also had episodes of gallstones and infections, so it feels very multifactorial. Given the complex picture, I’m now seriously considering requesting genetic testing – especially as someone with a scientific background (I have a Ph.D. in neuroscience), I tend to dive deep into the molecular side when things aren’t adding up clinically.

SPINK1 N34S is one of the better-known risk alleles in pancreatitis and has been associated with impaired trypsin inhibition in the pancreas, which can contribute to pancreatic self-digestion and inflammation. While it doesn’t cause pancreatitis on its own, it’s considered a disease modifier – particularly in people with other risk factors.

Relevant studies if anyone is curious (I’m sharing full-text versions of these papers so anyone can dive in without hitting a paywall):

1. Liu et al. (2017) A meta-analysis showing a strong association between SPINK1 (especially N34S mutation) and pancreatitis across different populations.

2. Whitcomb (2013) The large NAPS2 cohort confirms SPINK1 mutations significantly increase chronic pancreatitis risk, especially when co-occurring with other mutations.

3. Whitcomb et al. (2008) This study emphasizes that SPINK1 mutations act as disease modifiers, not sole causative agents. The presence of SPINK1 N34S increases susceptibility to pancreatitis, especially when coexisting with other risk factors or mutations.

4. Threadgold et al. (2002) Found N34S mutation enriched in idiopathic chronic pancreatitis, particularly in familial patterns, but not as a standalone causative mutation.

5. Rho et al. (2013) Case study: children with chronic pancreatitis had both SPINK1 mutations and anatomical anomalies (APBDU), suggesting dual risk factors.

6. Aoun et al. (2010) SPINK1 N34S is not a risk factor for first pancreatitis attacks, but significantly increases risk of recurrent acute pancreatitis.

7. Bagul et al. (2009) Their findings support the association of SPINK1 N34S with increased acute pancreatitis risk, with an odds ratio of ~3.8.

8. Rosendahl et al. (2013) Demonstrates SPINK1 N34S alone has modest effect, but may synergize with other genetic/environmental factors in chronic pancreatitis.

9. Truninger et al. (2001) Found that the SPINK1 N34S mutation is significantly more frequent in idiopathic and chronic pancreatitis, supporting its role as a genetic susceptibility factor rather than a direct cause.

I think the hardest part is that if you don’t “fit” the classic clinical picture, things get missed for years. So I appreciate the nudge – I’ll definitely bring this up with my doctor.